21
Mona Boaz, PhD, CV 2014
CURRICULUM VITAE
name: Mona Boaz, PhD ID# 303702864
faculty/dept: Department of Nutrition, School of Health Sciences, Ariel University
hospital/dept: Epidemiology and Research Unit, E. Wolfson Medical Center
Tel (Work): 03-502-8384
home address: Hacalanit 7 Apt 11 Raanana 45324
Email: Mobile Phone: 050-212-9666
date and place of birth: 26/10/1959, California, USA
date of arrival in israel: 29/06/1989
marital status: Married + 3
EducationUniversity of California, Los Angeles (UCLA), USA 1976-1980
(Name of University, City, Country) Period
Subject: Psychology
Degree or Professional License: BA Date Awarded: 1980
California State University, Los Angeles (CSULA) USA 1987-1989
(Name of University, City, Country) Period
Subject: Nutrition
Degree or Professional License: MSc Date Awarded: 1989
Supervised by: Prof. Margaret MacWilliams
Tel Aviv University, Ramat Aviv, Israel 1996-2001
(Name of University, City, Country) Period
Subject: Epidemiology
Degree or Professional License: PhD Date Awarded: 2001
Supervised by: Prof. Manfred Green, Prof. Menahem Fainaru
Title of Doctoral Dissertation: Secondary prevention using anti-oxidants of cardiovascular disease in end stage renal disease: SPACE
active participation in scientific meetings
Date / Country / Subject / Role
1997 / Switzerland / XXXIV Congress of the European Renal Association/European Dialysis and Transplant Association / Lecture, Award recipient
1999 / Spain / XXXVI Congress of the European Renal Association/European Dialysis and Transplant Association / Poster presentation
2000 / France / XXXVII Congress of the European Renal Association/European Dialysis and Transplant Association / Poster presentation
2001 / Italy / Annual Meeting of the European Society for Free Radical Research / Invited panelist
2002 / Denmark / 9 The XXXIX Congress of the European Renal Association/European Dialysis and Transplant Association / Poster presentation
2003 / USA / The 21st Annual Meeting of the International Society for Blood Purification / Invited speaker
2005 / USA / The 6th Annual Meeting on Diabetes Technology / Lecture
2006 / USA / American Diabetes Association 67th Scientific Sessions / Poster presentations
2007 / USA / The 8th Annual Meeting on Diabetes Technology / Poster presentations
2008 / Spain / The 3rd World Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension / Poster presentations
2009 / USA / American Diabetes Association 69th Scientific Sessions / Poster presentations
2010 / USA / 8th World Congress on Insulin Resistance, Cardiovascular Disease and Obesity / Poster presentations
2011 / USA / 8th International Conference on Functional Foods in Health and Disease / Invited lecturer
2011 / Israel / Preventive Nutrition / Invited lecturer
2011 / Israel / Nutrition in Israel / Invited lecturer, session chair
2011 / China / The 1 st Asia Pacific Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy) / Poster presentations
2012 / USA / 16th International Conference on Renal Nutrition and Metabolism / Session chair, conference faculty
membership in professional societies
Years (period) / Name of Organization
2001-present / Israel Diabetes Research Group
2001-present / Israel Diabetes Association
2009- present / European Renal and Cardiovascular Medicine Working Group (of the European Renal Association/European Dialysis and Transplant Association)
2011-present / Editorial Board, Journal of Functional Foods
2011 / Bariatric Research Forum
doctoral students Mentored
Years (period) / Name of Student / Subject / Academic Institute / Ph.D/ M.D
2011(with Dr. Eyal Leibovitz) / Sami Gyres / Malnutrition in newly hospitalized patients / Tel Aviv University / MD
2009-present (with Prof. Naftali Stern) / Tali Ganz / The effect of nutrition interventions and lifestyle changes on blood ADMA levels / Tel Aviv University / PhD
2012 (with Prof. Shlomo Berliner; Prof. Ami Sperber; Prof. Udi Ringel) / Keren Hod / The etiological role of intestinal inflammation and cholinergic status in the pathogenesis of irritable bowel syndrome (IBS) / Tel Aviv University / PhD
2012 (with Prof. Pierre Singer) / Abigail Navarro / Presentation and allocation of meals and high quality snacks in hospitalized patients / Tel Aviv University / PhD
M.A./M.Sc. Students Mentored:
Years (period) / Name of Student / Subject / Academic Institute
2004
(with Dr. Talia Weinstein) / Noga Garty / Malnutrition, inflammation and atherosclerosis (MIA syndrome) in hemodialysis patients: a cross-sectional study in Israel / Tel Aviv University
2005 (with Prof. Thelma Rosenthal) / Vered Courant / Coenzyme Q10 and ambulatory blood pressure measures in treated, hypertensive subjects, a randomized controlled clinical trial / Tel Aviv University
2006 / Larisa Shtendik / The effect of sevelamer hydrochloride (renagel) vs. calcium carbonate on calcium-phosphorus metabolism and total cholesterol in elderly hemodialysis patients / Clark University, Israel Academic College
2008
(with Dr. Julio Wainstein, Prof. Reuben Zimlichman) / Shimrit Heller / The effect of cinnamon on metabolic parameters in type 2 diabetes / Tel Aviv University
2011-2012 (with Prof. Zecharia Madar) / Hadas Rabinovitz / The effect of breakfast size on weight loss and glucose homeostasis in overweight, diabetic adults / Faculty of Agriculture, Hebrew University
Grants
Years / Investigator (Principal/,other) / Granted by Institute/Company / Total Amount
1996 / Mona Boaz / Tziporah Ayalon Foundation, Ramat Gan, Israel / NIS 10,000
1996 / Mona Boaz / Office of the Chief Scientist, Ministry of Health Grant #3525 / NIS 20,000
1998 / Mona Boaz / Office of the Chief Scientist Grant #4204 / NIS 60,000
2001 / Mona Boaz / Office of the Chief Scientist Grant #4204, extension / NIS 60,000
2003-7 / Mona Boaz, Talia Weinstein / Genzyme Therapeutics / $100,000
2011 / Mona Boaz, Talia Weinstein / Abbott Pharmaceuticals Research Grant / $30,000
2011 / Mona Boaz, Eyal Leibovitz / Abbott Pharmaceuticals / $10,000
SCIENTIFIC PUBLICATIONS
Articles Published
1. Boaz M, Smetana S. Regression equation predicts dietary phosphorus from estimate of dietary protein intake. J Am Diet Assoc 1996; 96:1268-1270. NUTRITION & DIETETICS IF = 3.244 R = 17 / 70
2. Boaz M, Green M, Smetana S. A comparison of dietary intake estimates in a population with chronic renal failure using modified diet history and a semiquantitative food frequency questionnaire. J Ren Nutr 1997; 113-123. NUTRITION & DIETETICS IF = 1.480 R = 46 / 70
3. Boaz M, Biro A, Katzir Z, Smetana S. Patterns of dietary intake and serum lipids interact with proteinuria as risk factors for progression of chronic renal failure. Renal Failure 1998; 20:383-390. UROLOGY & NEPHROLOGY IF = 0.790 R = 59 / 69
4. Serour F, Levine A, Mandelberg A, Ben Yehuda Y, Boaz M, Mori J. Alkalinizing local anesthetic does not decrease pain during injection for dorsal penile nerve block. J Clin Anesth 1999; 11:563-566. ANESTHESIOLOGY IF = 1.279 R = 18 / 26
5. Boaz M, Matas Z, Biro A, Katzir Z, Green M, Fainaru M, Smetana S. Comparison of hemostatic factors and serum malondialdehyde as predictive factors for cardiovascular disease in hemodialysis patients. American Journal of Kidney Diseases 1999; 34:439-445. UROLOGY & NEPHROLOGY IF = 5.242 R = 5 / 69
6. Boaz M, Matas Z, Biro A, Katzir Z, Green M, Fainaru M, Smetana S. Serum Malondialdehyde and prevalent cardiovascular disease in hemodialysis. Kidney International, 1999; 56:1078-1083. UROLOGY & NEPHROLOGY IF = 6.105 R = 3 / 69
7. Weinstein T, Chagnac A, Korzets A, Boaz M, Ori Y, Herman M, Malachi T, Gafter U. Haemolysis in haemodialysis patients: evidence for impaired defense mechanisms against oxidative stress. Nephrol Dial Transplant 2000 15:883-887. UROLOGY & NEPHROLOGY IF = 3.564 R = 12 / 69
8. Boaz M, Smetana S, Weinstein T, Matas Z, Gafter U, Iaina A, Knecht A, Weissgarten Y, Brunner D, Fainaru M, Green MS. Secondary prevention using antioxidants of cardiovascular disease in endstage renal disease:SPACE. The Lancet 2000 356:1213-1218. MEDICINE, GENERAL & INTERNAL IF = 33.633 R = 2 / 151
9. Lampl Y, Gilad R, Eschel Y, Boaz M, Rapoport A, Sadeh M. Diagnosing brain death using the transcranial Doppler with a transorbital approach. Arch Neurol 2002 59:58-60. CLINICAL NEUROLOGY IF = 7.108 R = 8 / 185
10. Serour F, Weissenberg M, Boaz M, Ezri T, Gorenstein A. Intravenous fluids warming by mattress is simple and efficient during pediatric surgery. Acta Anaesthesiol Scand 2002 46:80-84. ANESTHESIOLOGY IF = 2.196 R = 12 / 26
11. Serour F, Ben-Yehuda Y, Boaz M. EMLA cream prior to digital nerve block for Ingrown nail surgery does not reduce pain at injection of anesthetic solution. Acta Anaesthesiol Scand 2002 46:203-6. ANESTHESIOLOGY IF = 2.196 R = 12 / 26
12. Lampl Y, Eshel Y, Kessler A, Fux A, Gilad R, Boaz M, Matas Z, Sadeh M. Serum leptin level in women with idiopathic intracranial hypertension. J Neurol Neurosurg Psychiatry 2002 72:642-3. CLINICAL NEUROLOGY IF = 4.791 R = 22 / 185
13. Amsel S, Boaz M, Ballin A, Filk D, Ore N. Low compliance of iron supplementation in infancy and relation to socioeconomic status in Israel. Pediatrics 2002;110:410-1. PEDIATRICS IF = 5.391 R = 1 / 107
14. Sadan O, Ginath S, Rotmensch S, Boaz M, Golan A, Glezerman M. Role of steroid receptors in the pathogenesis of tubal pregnancy. J Reprod Med 2002 Dec;47:1031-4. OBSTETRICS & GYNECOLOGY IF = 0.883 R = 60 / 75
15. Brook U, Boaz M. Knowledge and attitudes of Israeli high school pupils towards alternative medicine. Patient Educ Couns 2003; 49:85-9. PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH IF = 2.237 R = 48 / 140
16. Sadan O, Ginath S, Gomel A, Abramov D, Rotmensch S, Boaz M, Glezerman M. What to do after a failed attempt of vacuum delivery? Eur J Obstet Gynecol Reprod Biol 2003; 107:151-5. OBSTETRICS & GYNECOLOGY IF = 1.764 R = 35 / 75
17. Hanukoglu A, Mizrachi A, Dalal I, Admoni O, Rakover Y, Bistritzer Z, Levine A, Somekh E, Lehmann D, Tuval M, Boaz M, Golander A. Extrapancreatic autoimmune manifestations in type 1 diabetes patients and their first-degree relatives: a multicenter study. Diabetes Care 2003; 26:1235-40. ENDOCRINOLOGY & METABOLISM IF = 7.141 R = 9 / 116
18. Shirin H, Sadan O, Shevah O, Bruck R, Boaz M, Moss SF, Everon S, Glezerman M, Avni Y. Positive serology for Helicobacter pylori and vomit ing in the pregnancy. Arch Gynecol Obstet. 2004; 270: 10-4. OBSTETRICS & GYNECOLOGY IF = 1.072 R = 56 / 75
19. Sadan O, Ginath S, Gomel A, Lurie S, Rotmench S, Golan A, Boaz M, Glezerman M. Vacuum application through a nonfully dilated cervix: a viable option. Arch Gynecol Obstet 2003; 268: 281-3. OBSTETRICS & GYNECOLOGY IF = 1.072 R = 56 / 75
20. Gorenstein A, Levine A, Boaz M, Mandelberg A, Serour F. Severity of acid gastroesophageal reflux assessed by pH metry: Is it associated with respiratory disease? Pediatr Pulmonol. 2003; 36: 330-4. PEDIATRICS IF = 2.239 R = 24/ 107
21. Boaz M, Smetana S, Matas Z, Bor A, Pinchuk I, Fainaru M, Green MS, Lichtenberg D. Lipid oxidation kinetics in hemodialysis patients with and without history of myocardial infarction. IMAJ 2003; 5: 692-696. MEDICINE, GENERAL & INTERNAL IF = 1.018 R = 83 / 155
22. Brook U, Boaz M. Children hospitalized for accidental injuries: Israeli experiences. Patient Educ Couns. 2003; 51: 177-82. MEDICINE, GENERAL & INTERNAL IF = 0.953 R = 84 / 151
23. Sadan O, Schejter E, Ginath S, Bachar R, Boaz M, Menczer J, Glezerman M. Premalignant lesions of the uterine cervix in a large cohort of Israeli Jewish women. Arch Gynecol Obstet 2004; 269:188-191. OBSTETRICS & GYNECOLOGY IF = 1.072 R = 56 / 75
24. Levine A, Milo T, Broide E, Wine E, Dalal I, Boaz M, Avni Y, Shirin H. Influence of Helicobacter pylori eradication on gastroesophageal reflux symptoms and epigastric pain in children and adolescents. Pediatrics 2004; 113(1 Pt 1): 54-58. PEDIATRICS IF = 5.391 R = 1 / 107
25. Kohelet D, Boaz M, Serour F, Cohen-Adad N, Arbel E, Gorenstein A. Esophageal pH study and symptomatology of gastroesophageal reflux in newborn infants. Am J Perinatol. 2004; 21: 85-91. OBSTETRICS & GYNECOLOGY IF = 1.118 R = 55 / 75
26. Abargel A, Avinoah I, Kravtsov V, Boaz M, Glazerman M, Menczer J. Expression of p27 and p53: comparative analysis of uterine carcinosarcoma and endometrial carcinoma. Int J Gynecol Cancer. 2004;14:354-359. OBSTETRICS & GYNECOLOGY IF = 1.558 R = 42/ 75
27. Shirin H, Birkenfeld S. Shevah O, Levine A, Epstein J, Boaz M, Niv Y, Avni Y. Application of Maastricht 2-2000 guidelines for the management of Helicobacter pylori among specialists and primary care physicians in israel: are we missing the malignant potential of Helicobacter pylori? J Clin Gastroenterol. 2004; 38: 322-325. GASTROENTEROLOGY & HEPATOLOGY IF = 2.752 R = 26 / 71
28. Weinstein T, Chagnac A, Boaz M, Ori Y, Herman M, Zevin D, Schmilovitz-Weiss H, Gafter U. Improved immunogenicity of a novel third-generation recombinant hepatitis B vaccine in patients with end-stage renal disease. Nephron Clin Pract 2004; 97: c67-72. UROLOGY & NEPHROLOGY IF = 1.843 R = 34 / 69
29. Levine A, Shevah O, Shabat-Sehayak V, Aeed H, Boaz M, Moss SF, Niv Y, Avni Y, Shirin H. Masking of 13C urea breath test by proton pump inhibitors is dependent on type of medication: comparison between omeprazole, pantoprazole, lansoprazole and esomeprazole. Aliment Pharmacol Ther 2004; 20:117-122. PHARMACOLOGY & PHARMACY IF = 3.861 R = 46 / 249
30. Evron S, Sessler D, Sadan O, Boaz M, Glezerman M, Ezri T. Identification of the epidural space: loss of resistance with air, lidocaine, or the combination of air and lidocaine. Anesth Analg. 2004; 99: 245-250. ANESTHESIOLOGY IF = 3.274 R = 5 / 26
31. Glinkova V, Shevah O, Boaz M, Levine A, Shirin H. Hepatic haemangiomas: possible association with female sex hormones. Gut. 2004; 53: 1352-1355. GASTROENTEROLOGY & HEPATOLOGY IF = 10.614 R = 3/ 71
32. Evron S, Glezerman M, Sadan O, Boaz M, Ezri T. Patient-controlled epidural analgesia for labor pain: effect on labor, delivery and neonatal outcome of 0.125% bupivacaine vs 0.2% ropivacaine. Int J Obstet Anesth 2004; 13:5-10. ANESTHESIOLOGY IF = 1.793 R = 15 / 26
33. Wine E, Reif SS, Leshinsky-Silver E, Weiss B, Shaoul RR, Shamir R, Wasserman D, Lerner A, Boaz M, Levine A. Pediatric Crohn's disease and growth retardation: the role of genotype, phenotype, and disease severity. Pediatrics 2004; 114:1281-6. PEDIATRICS IF = 5.391 R = 1 / 107